ALK: Subsidiary obtains approval number for "Amoxicillin Clavulanate Potassium Tablets" veterinary drug product

ALK announced that its subsidiary, Dongbao Technology, has received the approval document for the veterinary drug product "Amoxicillin Clavulanate Potassium Tablets" issued by the Ministry of Agriculture and Rural Affairs, with approval numbers 111183373 and 111183374. The validity period is from October 24, 2025, to October 23, 2030, with specifications of 50mg and 250mg. This product is used to treat bacterial infections in dogs and cats. This veterinary drug meets the conditions for production and market sales, which will enrich the company's product categories and promote the strategic layout of pet medications. However, there is uncertainty in market sales due to factors such as policies and market conditions